On the other hand, the clinical trials on semaglutide (Wegovy) for weight loss have been clear: On average, people taking that medication lose 15% of their body weight over 68 weeks compared to 2.4% of body weight in those taking a placebo
Some Anthem plans cover this indication when they exclude "weight loss." See our complete OSA coverage guide Other options if coverage isn't available: Self-pay via LillyDirect: Single-dose vials at $299/month (2.5mg) to $449/month (higher doses)prices reduced in late 2025 [11] Zepbound Cost Guide TrumpRx.gov: ~$346/month for Zepbound (launched Feb 5, 2026) [15] Foundayo: Eli Lilly's oral GLP-1 tablet (FDA approved April 1, 2026)no injections, may have different coverage Compare medications: Wegovy, Mounjaro & more Alternatives Guide Switch plans: Check other insurers during open enrollment WHAT'S CHANGING 2026 Outlook Major developments are reshaping GLP-1 access in 2026
Research has shown that glutathione levels are important for maintaining optimal liver function and protecting against liver damage
Folligon, Intervet International Bv
To understand this, we turned to single-cell approaches, and identified GLP-1 receptor expression in a very specific and previously underappreciated cell population: Pericentral liver sinusoidal endothelial cells (LSECs) We then tested whether these cells are functionally relevant